Clinical trials
Phase 2 Diabetic Nephropathies trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2019 | 1 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Pfizer | 2 |
| Aptabio Therapeutics, Inc. | 1 |
| Bayer | 1 |
| Curacle Co., Ltd. | 1 |
| Dong Wha Pharmaceutical Co. Ltd. | 1 |
| Korea Otsuka Pharmaceutical Co., Ltd. | 1 |
| Novartis Pharmaceuticals | 1 |
| Walden Biosciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetic Nephropathies | 11 |
| Diabetes Mellitus, Type 2 | 2 |
| Glomerulonephritis, IGA | 2 |
| Renal Insufficiency, Chronic | 2 |
| Albuminuria | 1 |
| Glomerulosclerosis, Focal Segmental | 1 |
| Heart Failure | 1 |
| Nephritis, Hereditary | 1 |
| Nephrosis, Lipoid | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.